Ouro Fino Saude Animal Overview
- Year Founded
-
1987
- Status
-
Public
- Employees
-
1,114
- Stock Symbol
-
OFSA3
- Share Price
-
$4.80
- (As of Friday Closing)
Ouro Fino Saude Animal General Information
Description
Ourofino SA is engaged in research, development, production and sales of medicines, vaccines and other veterinary products. The company's reportable segments are Production animals, Companion animals, and International operations. It generates maximum revenue from the Production animals segment. The product portfolio includes Anticoccidials, Antimastitics, Biological, Ectoparasiticides, Endectocides, and others.
Contact Information
Website
www.ourofinosaudeanimal.comCorporate Office
- Rodovia Anhanguera SP 330, Km 298
- Distrito Industrial, Cravinho
- Sao Paulo, 14140
- Brazil
Corporate Office
- Rodovia Anhanguera SP 330, Km 298
- Distrito Industrial, Cravinho
- Sao Paulo, 14140
- Brazil
Ouro Fino Saude Animal Stock Performance
As of 13-Nov-2026, Ouro Fino Saude Animal’s stock price is $4.80. Its current market cap is $258M with 53.8M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $4.80 | $4.83 | $3.99 - $7.01 | $258M | 53.8M | 4.84K | $0.83 |
Ouro Fino Saude Animal Financials Summary
As of 30-Jun-2026, Ouro Fino Saude Animal has a trailing 12-month revenue of $258M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 316,061 | 276,860 | 186,595 | 307,299 |
| Revenue | 257,785 | 218,878 | 190,182 | 188,726 |
| EBITDA | 59,501 | 51,801 | 45,498 | 25,349 |
| Net Income | 44,575 | 39,722 | 24,929 | (9,999) |
| Total Assets | 311,021 | 285,776 | 224,030 | 263,539 |
| Total Debt | 99,849 | 91,909 | 60,692 | 90,146 |
Ouro Fino Saude Animal Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Ouro Fino Saude Animal Comparisons
Industry
Financing
Details
Ouro Fino Saude Animal Competitors (3)
One of Ouro Fino Saude Animal’s 3 competitors is Elanco Animal Health, a Corporation company based in Indianapolis, IN.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Elanco Animal Health | Corporation | Indianapolis, IN | ||||
| Jurox | Corporate Backed or Acquired | Rutherford, Australia | ||||
| Nutreco | Formerly PE-Backed | Amersfoort, Netherlands |
Ouro Fino Saude Animal Patents
Ouro Fino Saude Animal Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3932943-A1 | Biologically active recombinant equine chorionic gonadotropin (recg) and process for obtaining same, veterinary composition and use | Inactive | 28-Feb-2019 | ||
| EP-3932943-A4 | Biologically active recombinant equine chorionic gonadotropin (recg) and process for obtaining same, veterinary composition and use | Inactive | 28-Feb-2019 | ||
| WO-2020172728-A1 | Biologically active recombinant equine chorionic gonadotropin (recg) and process for obtaining same, veterinary composition and use | Inactive | 28-Feb-2019 | ||
| EP-3398609-A1 | Process of producing a recombinant equine chorionic gonadotropin (recg), veterinary composition and use thereof | Inactive | 28-Dec-2015 | ||
| EP-3398609-A4 | Process of producing a recombinant equine chorionic gonadotropin (recg), veterinary composition and use thereof | Inactive | 28-Dec-2015 | A61K38/24 |
Ouro Fino Saude Animal Signals
Ouro Fino Saude Animal Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Ouro Fino Saude Animal ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Ouro Fino Saude Animal FAQs
-
When was Ouro Fino Saude Animal founded?
Ouro Fino Saude Animal was founded in 1987.
-
Where is Ouro Fino Saude Animal headquartered?
Ouro Fino Saude Animal is headquartered in Sao Paulo, Brazil.
-
What is the size of Ouro Fino Saude Animal?
Ouro Fino Saude Animal has 1,114 total employees.
-
What industry is Ouro Fino Saude Animal in?
Ouro Fino Saude Animal’s primary industry is Other Consumer Non-Durables.
-
Is Ouro Fino Saude Animal a private or public company?
Ouro Fino Saude Animal is a Public company.
-
What is Ouro Fino Saude Animal’s stock symbol?
The ticker symbol for Ouro Fino Saude Animal is OFSA3.
-
What is the current stock price of Ouro Fino Saude Animal?
As of 13-Nov-2026 the stock price of Ouro Fino Saude Animal is $4.80.
-
What is the current market cap of Ouro Fino Saude Animal?
The current market capitalization of Ouro Fino Saude Animal is $258M.
-
What is Ouro Fino Saude Animal’s current revenue?
The trailing twelve month revenue for Ouro Fino Saude Animal is $258M.
-
Who are Ouro Fino Saude Animal’s competitors?
Elanco Animal Health, Jurox, and Nutreco are competitors of Ouro Fino Saude Animal.
-
What is Ouro Fino Saude Animal’s annual earnings per share (EPS)?
Ouro Fino Saude Animal’s EPS for 12 months was $0.83.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process